Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Verna

Showing results (171-180 of 261) with videos related to

Pageof 27
Sort By:
Journal of Hepatology|December 13, 2021
TAZ-induced Cybb contributes to liver tumor formation in non-alcoholic steatohepatitisXiaobo Wang, Sharon Zeldin, Hongxue Shi, et al.
Clinical Transplantation|March 9, 2023
Living donor liver transplantation: A multi-disciplinary collaboration towards growth, consensus, and a change in cultureAnnMarie Liapakis, Michelle T Jesse, Anjana Pillai, et al.
The New England Journal of Medicine|December 14, 2016
Perioperative Ledipasvir-Sofosbuvir for HCV in Liver-Transplant RecipientsJosh Levitsky, Elizabeth C Verna, Jacqueline G O'Leary, et al.
Journal of Hepatology|May 8, 2014
A US multicenter study of hepatitis C treatment of liver transplant recipients with protease-inhibitor triple therapyJames R Burton, Jacqueline G O'Leary, Elizabeth C Verna, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 23, 2023
Outcomes of early vs late treatment initiation in solid organ transplantation from hepatitis C virus nucleic acid test-positive donors to hepatitis C virus-uninfected recipients: Results from the HCV-TARGET studyWesam Aleyadeh, Elizabeth C Verna, Hany Elbeshbeshy, et al.
Transplantation|February 26, 2015
Telaprevir- and Boceprevir-based Triple Therapy for Hepatitis C in Liver Transplant Recipients With Advanced Recurrent Disease: A Multicenter StudyElizabeth C Verna, Varun Saxena, James R Burton, et al.
Hepatology (Baltimore, Md.)|June 24, 2014
Standing the test of time: outcomes of a decade of prioritizing patients with hepatocellular carcinoma, results of the UNOS natural geographic experimentKarim J Halazun, Rachel E Patzer, Abbas A Rana, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 27, 2026
Frailty 1 year after liver transplant is associated with long-term mortality: From the Functional Assessment in Liver Transplantation (FrAILT) StudyMelinda Wang, Matthew R Kappus, Amy M Shui, et al.
Nature Communications|October 19, 2019
Colonizing multidrug-resistant bacteria and the longitudinal evolution of the intestinal microbiome after liver transplantationMedini K Annavajhala, Angela Gomez-Simmonds, Nenad Macesic, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 30, 2017
No country for old livers? Examining and optimizing the utilization of elderly liver graftsK J Halazun, A A Rana, B Fortune, et al.
Pageof 27

Showing results (171-180 of 261) with videos related to

Sort By:
Pageof 27
Journal of Hepatology|December 13, 2021
TAZ-induced Cybb contributes to liver tumor formation in non-alcoholic steatohepatitisXiaobo Wang, Sharon Zeldin, Hongxue Shi, et al.
Clinical Transplantation|March 9, 2023
Living donor liver transplantation: A multi-disciplinary collaboration towards growth, consensus, and a change in cultureAnnMarie Liapakis, Michelle T Jesse, Anjana Pillai, et al.
The New England Journal of Medicine|December 14, 2016
Perioperative Ledipasvir-Sofosbuvir for HCV in Liver-Transplant RecipientsJosh Levitsky, Elizabeth C Verna, Jacqueline G O'Leary, et al.
Journal of Hepatology|May 8, 2014
A US multicenter study of hepatitis C treatment of liver transplant recipients with protease-inhibitor triple therapyJames R Burton, Jacqueline G O'Leary, Elizabeth C Verna, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 23, 2023
Outcomes of early vs late treatment initiation in solid organ transplantation from hepatitis C virus nucleic acid test-positive donors to hepatitis C virus-uninfected recipients: Results from the HCV-TARGET studyWesam Aleyadeh, Elizabeth C Verna, Hany Elbeshbeshy, et al.
Transplantation|February 26, 2015
Telaprevir- and Boceprevir-based Triple Therapy for Hepatitis C in Liver Transplant Recipients With Advanced Recurrent Disease: A Multicenter StudyElizabeth C Verna, Varun Saxena, James R Burton, et al.
Hepatology (Baltimore, Md.)|June 24, 2014
Standing the test of time: outcomes of a decade of prioritizing patients with hepatocellular carcinoma, results of the UNOS natural geographic experimentKarim J Halazun, Rachel E Patzer, Abbas A Rana, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 27, 2026
Frailty 1 year after liver transplant is associated with long-term mortality: From the Functional Assessment in Liver Transplantation (FrAILT) StudyMelinda Wang, Matthew R Kappus, Amy M Shui, et al.
Nature Communications|October 19, 2019
Colonizing multidrug-resistant bacteria and the longitudinal evolution of the intestinal microbiome after liver transplantationMedini K Annavajhala, Angela Gomez-Simmonds, Nenad Macesic, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 30, 2017
No country for old livers? Examining and optimizing the utilization of elderly liver graftsK J Halazun, A A Rana, B Fortune, et al.
Pageof 27